William N William

William N William

UNVERIFIED PROFILE

Are you William N William?   Register this Author

Register author
William N William

William N William

Publications by authors named "William N William"

Are you William N William?   Register this Author

84Publications

2525Reads

36Profile Views

PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.

Head Neck 2019 Mar 16;41(3):615-622. Epub 2018 Dec 16.

The University of Texas MD Anderson Cancer Center, Department of Thoracic/Head and Neck Medical Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.25350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382518PMC
March 2019

Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial.

Cancer 2018 05 26;124(10):2169-2173. Epub 2018 Mar 26.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935588PMC
May 2018

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.

Ann Thorac Surg 2018 Feb 6;105(2):418-424. Epub 2017 Dec 6.

Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.08.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783769PMC
February 2018

Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial.

J Am Acad Dermatol 2017 Dec 28;77(6):1110-1113.e2. Epub 2017 Sep 28.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.07.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685879PMC
December 2017

PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.

Cancer Prev Res (Phila) 2017 Dec 10;10(12):684-693. Epub 2017 Oct 10.

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/lookup/doi/
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-17-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716880PMC
December 2017

Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Lung Cancer 2017 10 3;112:90-95. Epub 2017 Aug 3.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.034DOI Listing
October 2017

Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.

Thyroid 2017 05 16;27(5):672-681. Epub 2017 Feb 16.

1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0395DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802249PMC
May 2017

Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.

Thyroid 2017 01 29;27(1):81-87. Epub 2016 Nov 29.

5 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704769PMC
January 2017

Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.

J Clin Oncol 2017 Jan 21;35(3):352-360. Epub 2016 Nov 21.

Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick Zweidler-McKay, Diana Bell, William N. William Jr, Bonnie S. Glisson, J. Jack Lee, Andrew Futreal, Adel K. El-Naggar, and John V. Heymach, University of Texas MD Anderson Cancer Center, Houston; Michael J. Wick and Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Ann M. Kapoun, Leonardo Faoro, and Jakob Dupont, OncoMed Pharmaceuticals, Redwood City; Pamela Munster, University of California San Francisco, San Francisco, CA; and Gail Eckhardt, University of Colorado Denver School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.5264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456373PMC
January 2017

Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base.

Cancer 2016 11 15;122(21):3411-3412. Epub 2016 Jul 15.

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30193DOI Listing
November 2016

Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.

Future Oncol 2016 Oct 22;12(20):2379-86. Epub 2016 Jun 22.

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066140PMC
October 2016

Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.

Int J Radiat Oncol Biol Phys 2016 09 13;96(1):30-41. Epub 2016 Apr 13.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.03.053DOI Listing
September 2016

Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma.

Head Neck 2016 08 29;38(8):1258-62. Epub 2016 Mar 29.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24433DOI Listing
August 2016

Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.

Int J Radiat Oncol Biol Phys 2016 07 19;95(4):1117-31. Epub 2016 Mar 19.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.03.015DOI Listing
July 2016

Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.

J Clin Oncol 2016 06 16;34(16):1848-54. Epub 2016 Feb 16.

All authors: The University of Texas MD Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.6448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966344PMC
June 2016

Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.

Head Neck 2016 04 27;38 Suppl 1:E2091-9. Epub 2016 Feb 27.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24387DOI Listing
April 2016

Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.

Cancer 2016 Feb 10;122(4):534-45. Epub 2015 Nov 10.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742373PMC
February 2016

Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group.

J Clin Oncol 2016 Jan 2;34(2):186-93. Epub 2015 Nov 2.

Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS; Frank L. Meyskens Jr, University of California at Irvine, Irvine, CA; Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas J. George Jr, University of Florida, Gainesville, FL; Joanne M. Jeter, University of Arizona, Tucson, AZ; Shakila Khan, Mayo Clinic, Rochester, MN; Courtney A. Tyne, Feinstein Kean Healthcare, Washington, DC; and William N. William Jr, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070551PMC
January 2016

Induction chemotherapy for oral cavity cancer patients: Current status and future perspectives.

Oral Oncol 2015 Dec 27;51(12):1069-75. Epub 2015 Oct 27.

Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.10.009DOI Listing
December 2015

Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis.

Eur J Cancer 2015 Nov 26;51(17):2596-603. Epub 2015 Aug 26.

Department of Head and Neck Surgery and Otorhinolaryngology, AC. Camargo Cancer Center, São Paulo, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.08.007DOI Listing
November 2015

New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.

Cancer Prev Res (Phila) 2015 Nov 4;8(11):1027-35. Epub 2015 Sep 4.

Cancer Research Center of Lyon, UMR INSERM 1052-CNRS 5286, Lyon, France. Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France. Department of Medicine, Centre Léon Bérard, Lyon, France. Université de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777304PMC
November 2015

Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.

Am J Ophthalmol 2015 Aug 30;160(2):220-227.e2. Epub 2015 Apr 30.

Department of Plastic Surgery, Orbital Oncology and Ophthalmic Plastic Surgery Program, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2015.04.040DOI Listing
August 2015

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.

J Thorac Oncol 2015 Apr;10(4):682-90

*Department of Thoracic/Head & Neck Medical Oncology, †Department of Genomic Medicine, ‡Department of Biostatistics, §Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, The University of Texas, Houston TX; ‖Department of Medicine, Harvard Medical School, Mount Auburn Hospital, Cambridge, MA; and ¶Levine Cancer Institute, Carolina HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368494PMC
April 2015

A novel target for oral cancer chemoprevention? Notch quite, yet….

Cancer Prev Res (Phila) 2015 Apr 24;8(4):262-5. Epub 2015 Feb 24.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383667PMC
April 2015

HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.

Head Neck 2014 Nov 20;36(11):1547-54. Epub 2014 Mar 20.

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Otolaryngology - Head and Neck Surgery, Seoul National University Hospital and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010580PMC
November 2014

Sleep-related breathing disorders in patients with tumors in the head and neck region.

Oncologist 2014 Nov 1;19(11):1200-6. Epub 2014 Oct 1.

Departments of Pulmonary Medicine, Head & Neck Surgery, Biostatistics, Radiation Oncology, and Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221368PMC
November 2014

Thymoma complicated by acquired amegakaryocytic thrombocytopenia and pure red cell aplasia.

J Natl Compr Canc Netw 2014 Nov;12(11):1505-9

From the Department of Medicine, University of Texas Health Science Center; and the Department of Thoracic/Head and Neck Medical Oncology, Department of Hematopathology, and Section of Thrombosis & Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0149DOI Listing
November 2014

Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention.

Oral Oncol 2014 Oct 10;50(10):918-23. Epub 2014 Jan 10.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2013.12.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090290PMC
October 2014

Optimizing surrogate end points for preoperative systemic therapies in non-small cell lung cancers.

Ann Surg Oncol 2014 Sep 16;21(9):2813-4. Epub 2014 May 16.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3796-1DOI Listing
September 2014

Epidemiology of head and neck squamous cell cancer among HIV-infected patients.

J Acquir Immune Defic Syndr 2014 Apr;65(5):603-10

*Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, MI; ‡Department of Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX; §Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA; ‖Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY; ¶Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI; #Department of Otolaryngology/Head and Neck Surgery, Johns Hopkins University, Baltimore, MD; **Cancer Biology Program, University of Michigan, Ann Arbor, MI; ††Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, TX; §§Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA; and ‖‖Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999230PMC
April 2014

p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck.

Head Neck 2013 Nov 29;35(11):1527-33. Epub 2012 Oct 29.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23188DOI Listing
November 2013

Oral premalignancy: the roles of early detection and chemoprevention.

Otolaryngol Clin North Am 2013 Aug 25;46(4):579-97. Epub 2013 May 25.

Department of Maxillofacial Surgery, Pitié-Salpêtrière Hospital, 47-83 boulevard de l' Hôpital, Paris 75013, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.otc.2013.04.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734384PMC
August 2013

The role of systemic treatment before, during, and after definitive treatment.

Otolaryngol Clin North Am 2013 Aug 25;46(4):645-56. Epub 2013 May 25.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.otc.2013.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734377PMC
August 2013

Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.

Mol Cancer Ther 2013 Jun 20;12(6):1112-21. Epub 2013 Mar 20.

Department of Oral & Maxillofacial-Head & Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-1013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247265PMC
June 2013

Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.

Cancer Prev Res (Phila) 2013 May;6(5):375-8

Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683314PMC
May 2013

Oral premalignant lesions: any progress with systemic therapies?

Curr Opin Oncol 2012 May;24(3):205-10

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32835091bdDOI Listing
May 2012

Novel strategies for the treatment of small-cell lung carcinoma.

Nat Rev Clin Oncol 2011 Jun 21;8(10):611-9. Epub 2011 Jun 21.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2011.90
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2011.90DOI Listing
June 2011

Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.

Cancer 2010 May;116(10):2401-8

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145307PMC
May 2010

Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma.

Cancer 2010 May;116(10):2409-15

Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25076DOI Listing
May 2010

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

J Clin Oncol 2010 Jan 16;28(1):8-14. Epub 2009 Nov 16.

Departments of Thoracic/Head and Neck Medical Oncology, Head and Neck Surgery, Radiation Oncology, Biostatistics, Radiology, and Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.0425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799235PMC
January 2010

Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.

Chest 2009 Sep 24;136(3):701-709. Epub 2009 Mar 24.

Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.08-2968DOI Listing
September 2009

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.

Cancer 2009 Apr;115(8):1713-22

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142442PMC
April 2009

Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck.

Nat Clin Pract Oncol 2009 Mar 30;6(3):132-3. Epub 2009 Jan 30.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1321DOI Listing
March 2009

Molecular targets for cancer chemoprevention.

Nat Rev Drug Discov 2009 Mar;8(3):213-25

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd2663DOI Listing
March 2009

Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.

J Clin Oncol 2009 Feb 15;27(4):599-604. Epub 2008 Dec 15.

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.1850DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645856PMC
February 2009

Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.

Am J Clin Oncol 2009 Feb;32(1):15-9

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318178e513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120668PMC
February 2009

Cyclin D1 and cancer development in laryngeal premalignancy patients.

Cancer Prev Res (Phila) 2009 Jan;2(1):14-21

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243520PMC
January 2009

High-dose fenretinide in oral leukoplakia.

Cancer Prev Res (Phila) 2009 Jan;2(1):22-6

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161148PMC
January 2009

Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.

J Thorac Oncol 2007 Aug;2(8):745-50

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641531305
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31811f4719DOI Listing
August 2007